Interview with 2 Aphasia Experts

The ESCAS study (Efficacy and Safety of Cerebrolysin in the treatment of Aphasia after Acute Ischemic Stroke) was published in the reputable journal STROKE.

This important study shows that combination therapy of Cerebrolysin^® and speech therapy results in significantly better outcomes for aphasia patients than speech therapy alone.

We had the opportunity to speak with two leading aphasia experts:

• Dr. Alexander Thiel, Department of Neurology & Neurosurgery, McGill University, Canada
• Prof. Michał Karliński, Institute of Psychiatry and Neurology, Warsaw, Poland

The interview focuses on the challenges in post-stroke aphasia and the relevance of Cerebrolysin® in aphasia treatment.

Watch the video to gain exclusive expert insights!